For example, siRNA-mediated disruption of the APCCDH1-SKP2-p27Kip1 signaling pathway has been shown to promote exit from quiescence and enhance the efficacy of imatinib in a xenograft mouse model of gastrointestinal stromal tumors (GIST) (144). Here, SKP2 is linked to gastrointestinal stromal tumor.